HCAL
LXEO icon

HURRICANE CAPITAL ADVISORS LLC’s Lexeo Therapeutics LXEO Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,716
Closed -$32.8K – 878
2026
Q1 		$32.8K Buy
+5,716
New +$40.5K 0.01% 538

Other funds holding LXEO

Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's LXEO Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Lexeo Therapeutics (LXEO) in Q2 2026, closing a stake of 5,716 shares — an estimated $32.8K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in LXEO in Q1 2026 and held it in 1 quarter. The position peaked at $32.8K in Q1 2026. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Lexeo Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 5,716 Lexeo Therapeutics shares in Q2 2026, an estimated $32.8K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Lexeo Therapeutics in Q1 2026 and held it in 1 quarter.
  • HURRICANE CAPITAL ADVISORS LLC's Lexeo Therapeutics position peaked at $32.8K in Q1 2026.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.